CH Polman

4.4k total citations · 2 hit papers
50 papers, 3.0k citations indexed

About

CH Polman is a scholar working on Pathology and Forensic Medicine, Neurology and Rheumatology. According to data from OpenAlex, CH Polman has authored 50 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Pathology and Forensic Medicine, 17 papers in Neurology and 14 papers in Rheumatology. Recurrent topics in CH Polman's work include Multiple Sclerosis Research Studies (35 papers), Peripheral Neuropathies and Disorders (13 papers) and Systemic Lupus Erythematosus Research (8 papers). CH Polman is often cited by papers focused on Multiple Sclerosis Research Studies (35 papers), Peripheral Neuropathies and Disorders (13 papers) and Systemic Lupus Erythematosus Research (8 papers). CH Polman collaborates with scholars based in Netherlands, United Kingdom and Italy. CH Polman's co-authors include Frederik Barkhof, J.H.T.M. van Waesberghe, Rivka Ravid, Philip Scheltens, Alan J. Thompson, Wouter Kamphorst, J. Valk, M.A.A. van Walderveen, Leo de Sonneville and I. E. W. Reuling and has published in prestigious journals such as Brain, Neurology and Stroke.

In The Last Decade

CH Polman

49 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Axonal loss in multiple sclerosis lesions: Magnetic resonance imaging insights into substrates of disability

1999 586 citations CH Polman, Alan J. Thompson et al. profile →
Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis

1998 519 citations Philip Scheltens, CH Polman et al. Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
CH Polman Netherlands	24	2.2k	853	620	503	404	50	3.0k
Lawrence Jacobs United States	28	2.3k 1.0×	1.3k 1.5×	809 1.3×	473 0.9×	342 0.8×	56	3.6k
Darin T. Okuda United States	24	2.7k 1.2×	1.1k 1.3×	650 1.0×	589 1.2×	484 1.2×	113	3.4k
Jan Dörr Germany	36	1.8k 0.8×	631 0.7×	432 0.7×	373 0.7×	464 1.1×	76	3.3k
Paola Perini Italy	22	1.8k 0.8×	769 0.9×	532 0.9×	423 0.8×	314 0.8×	68	2.4k
O. R. Hommes Netherlands	27	2.7k 1.2×	1.3k 1.5×	854 1.4×	343 0.7×	419 1.0×	69	3.7k
Nynke F. Kalkers Netherlands	26	2.9k 1.3×	1.2k 1.5×	742 1.2×	269 0.5×	394 1.0×	40	3.4k
Deepa P. Ramasamy United States	34	2.1k 1.0×	938 1.1×	562 0.9×	622 1.2×	322 0.8×	107	3.0k
Clyde Markowitz United States	25	1.6k 0.7×	531 0.6×	464 0.7×	337 0.7×	295 0.7×	59	2.7k
Šarlota Mesaroš Serbia	28	1.8k 0.8×	622 0.7×	444 0.7×	520 1.0×	303 0.8×	95	2.4k
Robert Bermel United States	30	1.9k 0.9×	617 0.7×	519 0.8×	508 1.0×	483 1.2×	84	2.7k

Countries citing papers authored by CH Polman

Since Specialization

Citations

This map shows the geographic impact of CH Polman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by CH Polman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites CH Polman more than expected).

Fields of papers citing papers by CH Polman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by CH Polman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by CH Polman. The network helps show where CH Polman may publish in the future.

Co-authorship network of co-authors of CH Polman

This figure shows the co-authorship network connecting the top 25 collaborators of CH Polman. A scholar is included among the top collaborators of CH Polman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with CH Polman. CH Polman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Killestein, Joep, Veronica Popescu, Erikjan Rijkers, et al.. (2013). Oxysterols and cholesterol precursors correlate to magnetic resonance imaging measures of neurodegeneration in multiple sclerosis. Multiple Sclerosis Journal. 20(4). 412–417. 74 indexed citations

Ascherio, Alberto, Kassandra L. Munger, Chantal Simon, et al.. (2012). Serum 25-hydroxyvitamin D concentrations among patients in BENEFIT predicts conversion to multiple sclerosis, MRI lesions, and brain volume loss. UCL Discovery (University College London). 2 indexed citations

Metzig, Carola, Ludwig Kappos, CH Polman, et al.. (2011). Predictive nature of IgM anti-α-glucose serum biomarker for relapse activity and EDSS progression in CIS patients: a BENEFIT study analysis. Multiple Sclerosis Journal. 18(7). 966–973. 10 indexed citations

Tossberg, John T., Philip S. Crooke, Melodie A. Henderson, et al.. (2011). Gene-expression signatures: biomarkers toward diagnosing multiple sclerosis. Genes and Immunity. 13(2). 146–154. 18 indexed citations

Bodini, Benedetta, Marco Battaglini, Nicola De Stefano, et al.. (2010). T2 lesion location really matters: a 10 year follow-up study in primary progressive multiple sclerosis. Journal of Neurology Neurosurgery & Psychiatry. 82(1). 72–77. 44 indexed citations

Koetsier, J.C., et al.. (2009). Making a diagnosis in patients with an isolated spinal cord syndrome. Acta Neurologica Scandinavica. 81(3). 205–208.

Korteweg, T., Marco Rovaris, Massimo Filippi, et al.. (2008). Can rate of brain atrophy in multiple sclerosis be explained by clinical and MRI characteristics?. Multiple Sclerosis Journal. 15(4). 465–471. 14 indexed citations

Polman, CH, Ludwig Kappos, Mark S. Freedman, et al.. (2007). Subgroups of the BENEFIT study: Risk of developing MS and treatment effect of interferon beta-1b. Journal of Neurology. 255(4). 480–487. 55 indexed citations

Kappos, Ludwig, D. H. Miller, David MacManus, et al.. (2006). BG00012, a novel oral fumarate, is effective in patients with relapsing-remitting multiple sclerosis. UCL Discovery (University College London). 11 indexed citations

10.

Fisher, Elizabeth, Eva Havrdová, Michael Hutchinson, et al.. (2006). The effects of natalizumab on brain atrophy and cognitive function: results from the AFFIRM study. 1 indexed citations

11.

Scherder, Erik, Erik Ch. Wolters, CH Polman, J SERGEANT, & Dick F. Swaab. (2005). Pain in Parkinson's disease and multiple sclerosis: Its relation to the medial and lateral pain systems. Neuroscience & Biobehavioral Reviews. 29(7). 1047–1056. 59 indexed citations

12.

Sormani, Maria Pia, Paolo Bruzzi, K. Beckmann, et al.. (2005). The distribution of magnetic resonance imaging response to interferonβ–1b in multiple sclerosis. Journal of Neurology. 252(12). 1455–1458. 19 indexed citations

13.

Scolding, Neil, et al.. (2002). The recognition, diagnosis and management of cerebral vasculitis: a European survey. European Journal of Neurology. 9(4). 343–347. 31 indexed citations

14.

Sonneville, Leo de, Jan Boringa, I. E. W. Reuling, et al.. (2002). Information processing characteristics in subtypes of multiple sclerosis. Neuropsychologia. 40(11). 1751–1765. 159 indexed citations

15.

Jong, Brigit A. de, T. Huizinga, Eric Zanelli, et al.. (2002). Evidence for additional genetic risk indicators of relapse-onset MS within the HLA region. Neurology. 59(4). 549–555. 48 indexed citations

16.

Bruggen, J.P. ter, et al.. (1998). Ophthalmoplegic and lower cranial nerve variants merge into each other and into classical Guillain-Barr� syndrome. Muscle & Nerve. 21(2). 239–242. 29 indexed citations

17.

Emmen, Harry, et al.. (1994). The effects of 4‐aminopyridine on cognitive function in patients with multiple sclerosis. Neurology. 44(9). 1701–1701. 68 indexed citations

18.

Diemen, H.A.M. van, et al.. (1992). Evaluation of the visual system in multiple sclerosis: a comparative study of diagnostic tests. Clinical Neurology and Neurosurgery. 94(3). 191–195. 26 indexed citations

19.

Barkhof, Frederik, et al.. (1991). Serial quantitative MR assessment of optic neuritis in a case of neuromyelitis optica, using Gadolinium-?enhanced? STIR imaging. Neuroradiology. 33(1). 70–71. 11 indexed citations

20.

Bertelsmann, F.W., et al.. (1991). Sensitivity of eye movement registration and visual evoked potentials in evaluation of therapy in patients with multiple sclerosis. Journal of the Neurological Sciences. 102(1). 25–31. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact